Vaughan David Investments LLC Eli Lilly & CO Transaction History

Vaughan David Investments LLC

$4.35 Billion
Q3 2024

A detailed history of Vaughan David Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Vaughan David Investments LLC holds 2,207 shares of LLY stock, worth $1.75 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,207

Previous 2,056 7.34%

Holding current value

$1.75 Million

Previous $1.86 Million 4.99%

% of portfolio

0.04%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$772.14 - $960.02 $116,593 - $144,963	151 Added 7.34%	2,207 $1.96 Million
Q2 2024 Aug 07, 2024	SELL	$724.87 - $909.04 $1.28 Million - $1.6 Million	-1,765 Reduced 46.19%	2,056 $1.86 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $141,535 - $189,354	239 Added 6.67%	3,821 $2.97 Million
Q4 2023 Jan 29, 2024	SELL	$525.19 - $619.13 $22,583 - $26,622	-43 Reduced 1.19%	3,582 $2.09 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $8,694 - $11,986	20 Added 0.55%	3,625 $1.95 Million
Q2 2023 Aug 02, 2023	BUY	$350.74 - $468.98 $13,328 - $17,821	38 Added 1.07%	3,605 $1.69 Million
Q1 2023 May 02, 2023	SELL	$310.63 - $364.82 $5,591 - $6,566	-18 Reduced 0.5%	3,567 $1.23 Million
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $60,772 - $70,812	189 Added 5.57%	3,585 $1.31 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $9,783 - $11,149	33 Added 0.98%	3,396 $1.1 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $2,787 - $3,272	-10 Reduced 0.3%	3,363 $1.09 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $93,876 - $116,664	-400 Reduced 10.6%	3,373 $966,000
Q3 2021 Nov 04, 2021	BUY	$221.6 - $272.71 $99,720 - $122,719	450 Added 13.54%	3,773 $872,000
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $9,027 - $11,677	50 Added 1.53%	3,323 $763,000
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $11,502 - $14,890	70 Added 2.19%	3,273 $611,000
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $2,348 - $3,107	18 Added 0.57%	3,203 $541,000
Q2 2020 Aug 07, 2020	SELL	$136.42 - $164.18 $17,052 - $20,522	-125 Reduced 3.78%	3,185 $523,000
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $11,212 - $12,196	-105 Reduced 3.07%	3,310 $370,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $11,632 - $13,578	105 Added 3.17%	3,415 $378,000
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $5,295 - $5,932	-50 Reduced 1.49%	3,310 $383,000
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $18,889 - $23,608	-220 Reduced 6.15%	3,360 $361,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $13,247 - $15,204	175 Added 5.14%	3,580 $305,000
Q1 2018 May 04, 2018	SELL	$74.21 - $87.6 $14,841 - $17,520	-200 Reduced 5.55%	3,405 $263,000
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $16,388 - $17,578	200 Added 5.87%	3,605 $304,000
Q3 2017 Nov 09, 2017	SELL	$77.07 - $85.54 $199,611 - $221,548	-2,590 Reduced 43.2%	3,405 $291,000
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $175,488 - $194,774	2,277 Added 61.24%	5,995 $377,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,718	3,718 $306,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan David Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vaughan David Investments LLC with notifications on news.

Account

Vaughan David Investments LLC Eli Lilly & CO Transaction History